1. 92PNORTH/HGCSG1003: A phase II study evaluating the safety and efficacy of FOLFOX as adjuvant chemotherapy for patients with stage III colon cancer: Comparison with medical oncologists and surgeons. (25th November 2018) Authors: Iwanaga, I; Yuki, S; Kawamoto, Y; Nakatsumi, H; Takahashi, N; Shichinohe, T; Okuda, H; Ishiguro, A; Harada, K; Hatanaka, K; Oomori, K; Nakamura, M; Senmaru, N; Iwai, K; Koike, M; Ito, Y M; Taketomi, A; Hirano, S; Sakamoto, N; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 94PNORTH/HGCSG1003: North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer: Final analysis. (24th November 2019) Authors: Nakamura, M; Yuki, S; Takahashi, N; Shichinohe, T; Nakatsumi, H; Kawamoto, Y; Kusumi, T; Ishiguro, A; Harada, K; Iwanaga, I; Hatanaka, K; Oomori, K; Senmaru, N; Iwai, K; Koike, M; Sakamoto, N; Taketomi, A; Hirano, S; Nishimoto, N; Komatsu, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-090North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer: final analysis (NORTH/HGCSG1003). (2nd July 2019) Authors: Ishiguro, A; Yuki, S; Takahashi, N; Shichinohe, T; Nakatsumi, H; Kawamoto, Y; Kusumi, T; Harada, K; Iwanaga, I; Hatanaka, K; Oomori, K; Nakamura, M; Senmaru, N; Iwai, K; Koike, M; Sakamoto, N; Taketomi, A; Hirano, S; Ito, Y M; Komatsu, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-223NORTH/HGCSG1003: A phase II study evaluating the safety and efficacy of FOLFOX as adjuvant chemotherapy for patients with stage III colon cancer: Comparison with medical oncologists and surgeons. (20th June 2018) Authors: Yuki, S; Komatsu, Y; Kawamoto, Y; Nakatsumi, H; Takahashi, N; Shichinohe, T; Okuda, H; Ishiguro, A; Harada, K; Iwanaga, I; Hatanaka, K; Oomori, K; Nakamura, M; Senmaru, N; Iwai, K; Koike, M; Shinohara, T; Miyashita, K; Ito, Y M; Taketomi, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P-223NORTH/HGCSG1003: A phase II study evaluating the safety and efficacy of FOLFOX as adjuvant chemotherapy for patients with stage III colon cancer: Comparison with medical oncologists and surgeons. (20th June 2018) Authors: Yuki, S; Komatsu, Y; Kawamoto, Y; Nakatsumi, H; Takahashi, N; Shichinohe, T; Okuda, H; Ishiguro, A; Harada, K; Iwanaga, I; Hatanaka, K; Oomori, K; Nakamura, M; Senmaru, N; Iwai, K; Koike, M; Shinohara, T; Miyashita, K; Ito, Y M; Taketomi, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗